Skip to main content
. 2022 Aug 15;12(4):125–135.

Table 1.

Effects of Al-hijamah on some immunological parameters of thalassemic patients

Patient’s number Before Al-hijamah After Al-hijamah


CD4+ T cell count (cells/mm3) CD8+ T cell count (cells/mm3) CD4/CD8 ratio TAC/MDA ratio CD4+ T cell count (cells/mm3) CD8+ T cell count (cells/mm3) CD4/CD8 ratio TAC/MDA ratio
1 150 108 1.39 8 183 118 1.55 42.14
2 31 28 1.11 13 343 258 1.33 35.08
3 35 70 0.5 13.7 185 125 1.48 45.088
4 42 88 0.48 11.5 168 105 1.6 51.8
5 44 71 0.618 6.8 965 729 1.32 72.86
6 60 32 1.878 10.2 150 76 1.97 50.7
7 200 184 1.09 5.4 709 293 2.41 30.6
8 53 43 1.23 7.1 116 550 0.21 39.33
9 108 73 1.45 13 724 235 3.08 47
10 77 35 2.2 9.5 532 79 6.73 85.14
11 450 552 0.82 6.2 124 322 0.39 80.26
12 15 33 0.45 8.6 186 113 1.65 28.14
13 425 200 2.13 0.5 350 258 1.36 58.4
14 283 73 3.88 9.6 183 125 1.46 42.96
15 31 58 0.53 4.9 343 105 3.27 73.45
16 50 61 0.82 8.2 185 729 0.25 52.03
17 60 32 1.88 4.7 67 150 0.45 52.98
18 300 200 1.5 11.11 709 293 2.42 87.34
19 53 43 1.23 10.15 116 550 0.21 80
20 15 22 0.68 8.4 186 235 0.79 49.29
Mean 124.1 100.3 1.29 8.5 326.2 272.4 1.70 55.23
SD 135.32 120.04 0.82 3.3 259.11 207.41 1.49 18.34
SEM 30.27 26.85 0.18 0.37 57.97 46.34 0.33 4.1